Randomized phase III study of 3-weekly versus weekly docetaxel in pretreated advanced non-small-cell lung cancer: a Spanish Lung Cancer Group trial.

Source:http://linkedlifedata.com/resource/pubmed/id/16371411

Download in:

View as

General Info

PMID
16371411